Stronger, together.
At Eleveya, we believe that the most powerful solutions emerge when diverse voices come together. Through our coalition platforms, we unite stakeholders across sectors, geographies, and perspectives to tackle shared challenges. With a strategic and hands-on approach, we help build, manage, and sustain high-impact collaborations—turning collective vision into meaningful action. We have conceived a number of private sector alliances, multi-stakeholder collaborations, and cause-driven movements. Check some of the examples below.
Image Credits: The Global Fund
The Private Sector Consituency of the Global Fund to Fight AIDS, Malaria and Tuberculosis
Bringing The Private Sector Voice to the Global Fund.
The Global Fund Private Sector Constituency (PSC) unites the diverse voices, expertise, and innovation of the private sector to contribute meaningfully to the Global Fund’s governance and impact. As the entity responsible for managing the private sector’s designated seat on the Global Fund Board, we ensure adequate representation of PSC - private sector’s perspectives in decision-making. By leveraging its members’ technical capabilities, advocacy strength, and resources, the PSC supports the Global Fund’s mission to expand access to prevention, care, and treatment for HIV/AIDS, TB, and malaria worldwide.
The Business Alliance Against Malaria, official private sector voice at the RBM Partnership to End Malaria.
Our Generation can defeat malaria. For Good.
The Business Alliance Against Malaria (BAAM) is the only platform that unites companies across industries and continents to bring multi-sector expertise and strategic partnership to the fight against malaria. Together, we aim to shape global and regional policy, mobilize stakeholders and bolster the work of those who share our vision of a malaria-free world. We have a dual mandate: to commit to a duty of care in providing guidance and support to the RBM Partnership to End Malaria as active members of its Board, and to serve as a platform for malaria innovators and thought leaders to share ideas, strategize and change the future.
Image Credits: WHO/Mekong Malaria Elimination (MME) Programme
The Stop TB Partnership’s Private Sector Constituency.
Uniting Private Sector to fight the deadliest infectious disease.
We unite private-sector companies who have come together from all walks of life, leveraging shared knowledge, capabilities and commitment, to fight the tuberculosis epidemic. We do so through individual and collective action, awareness raising and, shaping global strategies - providing unique perspectives to the board of the Stop TB Partnership.
Image Credits: FIND, Ben Phillips
The World Coalition on Sickle Cell Disease.
Shaping a world in which all individuals living with Sickle Cell Disease get the care and support they need to thrive.
Sickle Cell Disease (SCD) is a genetic blood disorder that affects millions of people worldwide, causing immense pain and suffering, especially in children. Despite its significant disease burden and recognition by the World Health Organization (WHO) as a public health priority, SCD has been largely absent from global and national health agendas.
Insufficient resource mobilisation and inadequate funding for program implementation in high-burden countries are the primary barriers to advancing efforts to tackle the disease.
To address these challenges, the World Coalition on Sickle Cell Disease provides a unique platform for elevating SCD and enhancing coordinated action on a global scale.
The Fight the Fakes Alliance
The only multi-sectoral alliance dedicated to raise awareness and fight substandard and falsified medicines.
Fight the Fakes (FTF) Alliance (commonly referred to as ‘Fight the Fakes’) is a multi-stakeholder non-profit association that aims to raise awareness and influence change about the proliferation of substandard and falsified medicines. Substandard and falsified medicines not only put patients’ lives at risk but undermine trust in healthcare systems and modern medicine, and hamper crucial progress made so far by countries towards universal health coverage.
With over 20 members representing health care professionals, manufacturers, wholesalers, researchers and patients, the Alliance is uniquely positioned to scale up action to prevent falsified medicines from endangering people’s health and well-being. Alliance partners endorse our activities and share the belief that coordination among all relevant stakeholders involved in the manufacturing and distribution of medicines is vital to tackle this global health threat.